Jerome Williams

Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents

Gregg W. Stone, Mark Midei, William Newman et al. · Circulation · 2009 · 297 citations · Full text

Medicine, Cardiology, Surgery +17

Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

Gregg W. Stone, Stephen G. Ellis, Tommaso Gori et al. · The Lancet · 2018 · 141 citations

Medicine, Cardiology, Clinical Sciences +17

Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)

Robert J. Applegate, Manejeh Yaqub, James Hermiller et al. · The American Journal of Cardiology · 2011 · 41 citations

Medicine, Cardiology, Interventional Cardiology +13

Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

Alexandra J. Lansky, Manejeh Yaqub, James Hermiller et al. · EuroIntervention · 2010 · 27 citations

Medicine, Cardiology, Cardiothoracic Surgery +13

Evaluation of the effects of everolimus‐eluting and paclitaxel‐eluting stents on target lesions with jailed side branches: 2‐year results from the SPIRIT III randomized trial

Robert J. Applegate, James Hermiller, Jerome Williams et al. · Catheterization and Cardiovascular Interventions · 2010 · 21 citations

Medicine, Cardiology, Surgery +17